Balchem Co. (NASDAQ:BCPC) Shares Sold by Sei Investments Co.

Sei Investments Co. trimmed its stake in shares of Balchem Co. (NASDAQ:BCPC) by 1.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 107,424 shares of the basic materials company’s stock after selling 1,757 shares during the period. Sei Investments Co. owned about 0.33% of Balchem worth $17,510,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. FMR LLC raised its holdings in Balchem by 944.3% during the third quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock worth $87,559,000 after purchasing an additional 449,854 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in shares of Balchem in the fourth quarter valued at $23,628,000. Raymond James Financial Inc. acquired a new position in shares of Balchem during the 4th quarter worth $13,359,000. Barclays PLC boosted its position in shares of Balchem by 405.8% in the 3rd quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock worth $10,695,000 after buying an additional 48,762 shares in the last quarter. Finally, Geneva Capital Management LLC grew its stake in Balchem by 5.1% in the 4th quarter. Geneva Capital Management LLC now owns 819,746 shares of the basic materials company’s stock valued at $133,615,000 after acquiring an additional 39,877 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Balchem Stock Performance

Shares of NASDAQ BCPC opened at $166.11 on Friday. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03. The company has a market cap of $5.40 billion, a PE ratio of 42.27, a price-to-earnings-growth ratio of 4.41 and a beta of 0.63. The company has a 50-day simple moving average of $165.18 and a 200-day simple moving average of $169.26. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16.

Balchem (NASDAQ:BCPC) last released its earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). Balchem had a net margin of 13.47% and a return on equity of 11.37%. The business had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. On average, equities analysts anticipate that Balchem Co. will post 4.64 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have issued reports on BCPC. StockNews.com downgraded shares of Balchem from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Sidoti upgraded Balchem to a “hold” rating in a report on Tuesday, February 25th. Finally, HC Wainwright reissued a “buy” rating and issued a $190.00 price target on shares of Balchem in a report on Monday, February 24th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.